Anti-Cytochrome P450 3A7 [F19P2H2]
Invented by Ayham Alnabulsi from Vertebrate Antibodies Limited
Invented at Vertebrate Antibodies Limited
- Datasheet
- References (6)
- Inventor Info
Info
![Image thumbnail for Anti-Cytochrome P450 3A7 [F19P2H2]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/23ce91c8-a6af-4596-9e85-a7e93406cf73.jpg)
![Image thumbnail for Anti-Cytochrome P450 3A7 [F19P2H2]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/b3d55533-f3b9-421a-823f-5abb2c23b8c2.jpg)
| Catalogue Number | 151864 |
| Applications | ELISA IHC WB |
| Antigen/Gene or Protein Targets | CYP3A7- Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (P450-HFLA) |
| Reactivity | Human |
| Relevance | This monoclonal antibody (MAb), when used in conjunction with the Mab specific to CYP3A5 clone F18 P3 B6, is able to differentiate between the CYP450 family 3 members: CYP3A5 and CYP3A7 |
| Host | Mouse |
| Immunogen | Ovalbumin-conjugated synthetic peptide ESRDETVSGA (C-terminal sequence) |
| Positive Control | IHC: formalin-fixed, paraffin-embedded prostate cancer sections. Western blot: recombinant P450 (shown below @ 0.5 pmol per lane). Negative control: Gentest Cat. No M101b. |
| Subclass | IgG1 kappa |
| Strain | Balb/c |
| Research Area | Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism |
References: 6 entries
Zia et al. 2015. Int J Exp Pathol. 96(2):81-6. PMID: 25670065.
CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation.
Europe PMC ID: 25670065
Downie et al. 2005. Clin Cancer Res. 11(20):7369-75. PMID: 16243809.
Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.
Europe PMC ID: 16243809
Kumarakulasingham et al. 2005. Clin Cancer Res. 11(10):3758-65. PMID: 15897573.
Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.
Europe PMC ID: 15897573
Add a reference
References: 6 entries
Zia et al. 2015. Int J Exp Pathol. 96(2):81-6. PMID: 25670065.
CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation.
Downie et al. 2005. Clin Cancer Res. 11(20):7369-75. PMID: 16243809.
Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.
Kumarakulasingham et al. 2005. Clin Cancer Res. 11(10):3758-65. PMID: 15897573.
Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.
Add a reference
